Abstract:Seryl-tRNA synthetases (SerRSs), members of the aminoacyl-tRNA synthetase family, interact with diverse proteins, enabling SerRSs to enhance their role in the translation of the genetic message or to perform alternative functions in cellular processes beyond translation. Atypical archaeal SerRS interacts with arginyl-tRNA synthetase and proteins of the ribosomal P-stalk to optimize translation through tRNA channeling. The complex between yeast SerRS and peroxin Pex21p provides a connection between translation and peroxisome function. The partnership between Arabidopsis SerRS and BEN1 indicates a link between translation and brassinosteroid metabolism and may be relevant in plant stress response mechanisms. In Drosophila, the unusual heterodimeric mitochondrial SerRS coordinates mitochondrial translation and replication via interaction with LON protease. Evolutionarily conserved interactions of yeast and human SerRSs with m3C32 tRNA methyltransferases indicate coordination between tRNA modification and aminoacylation in the cytosol and mitochondria. Human cytosolic SerRS is a cellular hub protein connecting translation to vascular development, angiogenesis, lipogenesis, and telomere maintenance. When translocated to the nucleus, SerRS acts as a master negative regulator of VEGFA gene expression. SerRS alone or in complex with YY1 and SIRT2 competes with activating transcription factors NFκB1 and c-Myc, resulting in balanced VEGFA expression important for proper vascular development and angiogenesis. In hypoxia, SerRS phosphorylation diminishes its binding to the VEGFA promoter, while the lack of nutrients triggers SerRS glycosylation, reducing its nuclear localization. Additionally, SerRS binds telomeric DNA and cooperates with the shelterin protein POT1 to regulate telomere length and cellular senescence. As an antitumor and antiangiogenic factor, human cytosolic SerRS appears to be a promising drug target and therapeutic agent for treating cancer, cardiovascular diseases, and possibly obesity and aging.

Seryl-tRNA synthetase promotes translational readthrough by mRNA binding and involvement of the selenocysteine incorporation machinery

Genomic Organization, Expression, and Subcellular Localization of Mouse Mitochondrial Seryl-Trna Synthetase.

A Versatile Strategy to Reduce UGA-Selenocysteine Recoding Efficiency of the Ribosome Using CRISPR-Cas9-Viral-Like-Particles Targeting Selenocysteine-tRNA[Ser]Sec Gene

SRSF2 plays an unexpected role as reader of m 5 C on mRNA, linking epitranscriptomics to cancer

Protein–Protein Interactions of Seryl-tRNA Synthetases with Emphasis on Human Counterparts and Their Connection to Health and Disease

Mammalian proteome expansion by stop codon readthrough

Human selenocysteine synthase, SEPSECS, has evolved to optimize binding of a tRNA-based substrate

Structural and Biochemical Studies of the Human Selenocysteine tRNA-Specific Elongation Factor eEFSec

Increased expression of tryptophan and tyrosine tRNAs elevates stop codon readthrough of reporter systems in human cell lines

Transcriptome-wide investigation of stop codon readthrough in Saccharomyces cerevisiae

Translation termination codons in protein synthesis and disease

Selenocysteine Insertion at a Predefined UAG Codon in a Release Factor 1 (RF1)-depleted Escherichia coli Host Strain Bypasses Species Barriers in Recombinant Selenoprotein Translation*

Processive selenocysteine incorporation during synthesis of eukaryotic selenoproteins

Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3

Structure of the mammalian ribosome as it decodes the selenocysteine UGA codon

Recognition of the mRNA selenocysteine insertion sequence by the specialized translational elongation factor SELB

A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion

Selective Degradation of Trnaser(agy) is the Primary Driver for Mitochondrial Seryl-Trna Synthetase-Related Disease.

The selective chemical modification of the 6-amino group of adenosine of the premature termination codon induces readthrough to produce full-length peptide in the reconstituted E. Coli translation system

Unearthing a novel function of SRSF1 in binding and unfolding of RNA G-quadruplexes

New Directions for Understanding the Codon Redefinition Required for Selenocysteine Incorporation